Survival after diagnosis of AIDS: A prospective observational study of 2625 patients

被引:51
作者
Mocroft, A
Youle, M
Morcinek, J
Sabin, CA
Gazzard, B
Johnson, MA
Phillips, AN
机构
[1] ROYAL FREE HOSP,DEPT THORAC MED,LONDON NW3 2PF,ENGLAND
[2] CHELSEA & WESTMINSTER HOSP,KOBLER CTR,ST STEPHENS CLIN,LONDON SW10 9TH,ENGLAND
关键词
D O I
10.1136/bmj.314.7078.409
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To estimate median survival and changes in survival in patients diagnosed as having AIDS. Design: Prospective observational study. Setting: Clinics in two large London hospitals. Subjects: 2625 patients with AIDS seen between 1982 and July 1995. Main outcome measures: Survival, estimated using lifetable analyses, and factors associated with survival, identified from Cox proportional hazards models. Results: Median survival (20 months) was longer than previous estimates. The CD4 lymphocyte count at or before initial AIDS defining illness decreased significantly over time from 90 x 10(6)/l during 1987 or earlier to 40x10(6)/l during 1994 and 1995 (P < 0.0001). In the first three months after diagnosis, patients in whom AIDS was diagnosed after 1987 had a much lower risk of death (relative risk 0.44, 95% confidence interval 0.22 to 0.86; P=0.0.017) than patients diagnosed before 1987. When the diagnosis was based on oesophageal candidiasis or Kaposi's sarcoma, patients had a lower risk of death than when the diagnosis was based on Pneumocystis carinii pneumonia (0.21 (0.07 to 0.59), P=0.0030 and 0.37 (0.16 to 0.83), P=0.016). Three months after AIDS diagnosis, the risk of death was similar in patients whose diagnosis was made after and before 1987 (1.02 (0.79 to 1.31), P=0.91). There were no differences in survival between patients diagnosed during 1958-90, 1991-3, or 1994-5. Conclusions:In later years, patients were much more likely to survive their initial illness, but long term survival has remained poor. The decrease in CD4 lymphocyte count at AIDS diagnosis indicates that patients are being diagnosed as having AIDS at ever more advanced stages of immunodeficiency.
引用
收藏
页码:409 / 413
页数:7
相关论文
共 31 条
[1]  
[Anonymous], [No title captured]
[2]  
[Anonymous], 1987, MMWR-MORBID MORTAL W
[3]   TRENDS IN SURVIVAL AMONG PERSONS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME IN NEW-YORK-CITY - THE EXPERIENCE OF THE FIRST DECADE OF THE EPIDEMIC [J].
BLUM, S ;
SINGH, TP ;
GIBBONS, J ;
FORDYCE, EJ ;
LESSNER, L ;
CHIASSON, MA ;
WEISFUSE, IB ;
THOMAS, PA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 139 (04) :351-361
[4]  
[Anonymous], 1992, MMWR Recomm Rep, V41, P1
[5]   SURVIVAL AND MORTALITY PATTERNS OF AN ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS) COHORT IN NEW-YORK-STATE [J].
CHANG, HGH ;
MORSE, DL ;
NOONAN, C ;
COLES, B ;
MIKL, J ;
ROSEN, A ;
PUTNAM, D ;
SMITH, PF .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 138 (05) :341-349
[6]   DETERMINANTS OF SURVIVAL IN ADULT BRAZILIAN AIDS PATIENTS, 1982-1989 [J].
CHEQUER, P ;
HEARST, N ;
HUDES, ES ;
CASTILHO, E ;
RUTHERFORD, G ;
LOURES, L ;
RODRIGUES, L .
AIDS, 1992, 6 (05) :483-487
[7]  
DOURNON E, 1988, LANCET, V2, P1297
[8]   Survival from early, intermediate, and late stages of HIV infection [J].
Enger, C ;
Graham, N ;
Peng, Y ;
Chmiel, JS ;
Kingsley, LA ;
Detels, R ;
Munoz, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (17) :1329-1334
[9]   SAFETY AND EFFICACY OF SULFAMETHOXAZOLE AND TRIMETHOPRIM CHEMOPROPHYLAXIS FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN AIDS [J].
FISCHL, MA ;
DICKINSON, GM ;
LAVOIE, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 259 (08) :1185-1189
[10]   THE EFFICACY OF AZIDOTHYMIDINE (AZT) IN THE TREATMENT OF PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
FISCHL, MA ;
RICHMAN, DD ;
GRIECO, MH ;
GOTTLIEB, MS ;
VOLBERDING, PA ;
LASKIN, OL ;
LEEDOM, JM ;
GROOPMAN, JE ;
MILDVAN, D ;
SCHOOLEY, RT ;
JACKSON, GG ;
DURACK, DT ;
KING, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (04) :185-191